Gertsch Timothy 4
4 · agilon health, inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Gertsch Timothy
Chief Accounting Officer
Transactions
- Exercise/Conversion
Options (Rights to Buy)
2023-09-11−8,750→ 8,750 totalExercise: $4.50Exp: 2030-07-29→ Common Stock (8,750 underlying) - Exercise/Conversion
Common Stock
2023-09-11$8.99/sh+17,500$157,325→ 34,621 total - Exercise/Conversion
Common Stock
2023-09-11$4.50/sh+8,750$39,375→ 25,871 total - Sale
Common Stock
2023-09-11$18.61/sh−8,750$162,838→ 17,121 total - Sale
Common Stock
2023-09-11$18.62/sh−17,500$325,778→ 17,121 total - Exercise/Conversion
Options (Rights to Buy)
2023-09-11−17,500→ 8,750 totalExercise: $8.99Exp: 2030-07-29→ Common Stock (17,500 underlying)
Footnotes (5)
- [F1]Includes restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.61 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.60 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]These options were granted on July 29, 2020, and became vested as of June 29, 2022 and June 29, 2023.
- [F5]These options were granted on July 29, 2020, and became vested as of June 29, 2023.